Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Wyeth Pharmaceuticals announces positive CHMP opinion for CONBRIZA for postmenopausal osteoporosis in women
Wyeth Pharmaceuticals announces positive CHMP opinion for CONBRIZA for postmenopausal osteoporosis in women
Wyeth Pharmaceuticals announces positive CHMP opinion for CONBRIZA for postmenopausal osteoporosis in women
Submitted by
admin
on February 20, 2009 - 8:24am
Source:
Trading Markets
News Tags:
Wyeth
CONBRIZA
osteoporosis
Headline:
Wyeth Pharmaceuticals announces positive CHMP opinion for CONBRIZA for postmenopausal osteoporosis in women
Do Not Allow Advertisers to Use My Personal information
